Wednesday, September 06, 2023
Axogen, Inc., a prominent player in advancing innovative surgical solutions for peripheral nerve injuries globally, has officially introduced the Axoguard HA+ Nerve Protector.
Karen Zaderej, the Chairman, CEO, and President of Axogen, emphasized the significance of Axoguard HA+ as an expansion of their nerve protection platform. She affirmed, "The introduction of Axoguard HA+ broadens the possibilities for surgeons to address a wider spectrum of nerve protection challenges."
The Axoguard HA+ Nerve Protector stands as an exclusive nerve protection device meticulously designed to offer both short- and long-term protection for peripheral nerve injuries. It comprises a processed porcine submucosa extracellular matrix base layer with a hyaluronate-alginate gel coating. This gel layer enhances nerve gliding, diminishing the potential for soft tissue attachments, while the base layer gradually transforms into a robust protective tissue layer over time.
The domain of nerve protection encompasses a diverse range of injuries and defects, including nerve compression, crush injuries, and complex traumatic injuries. These varied injury types, situated in different anatomical locations, pose unique challenges for both surgeons and patients. Achieving the best possible outcomes necessitates customized solutions that effectively address the nerve and its surrounding environment throughout the healing process.
Dr. Peter J. Evans, MD, PhD, Division Chair of Orthopedic Surgery at the Cleveland Clinic Florida Region, underscored the potential impact of Axoguard HA+ on patients with compression nerve injuries, particularly those near highly mobile joints. He pointed out that the enhanced gliding feature and improved handling of the Axoguard HA+ Nerve Protector empower surgeons to effectively confront the challenges associated with these injuries during the critical early stages of healing.